glucagon has been researched along with beta-alanine in 7 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (beta-alanine) | Trials (beta-alanine) | Recent Studies (post-2010) (beta-alanine) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 3,177 | 207 | 1,807 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Block, ER; Bode, BP; Herskowitz, K; Souba, WW | 1 |
| Aussel, C; Cynober, L; De Bandt, JP; Giboudeau, J; Lim, SK; Pernet, P | 1 |
| Candelore, MR; Dallas-Yang, Q; Guo, J; Jiang, G; Liang, R; McCann, PE; Miller, C; Parmee, ER; Qureshi, SA; Shang, J; Tata, JR; Tong, X; Tota, LM; Vincent, SH; Wright, MJ; Xiong, Y; Xu, SS; Yang, X; Zhang, BB | 1 |
| Brady, EJ; Candelore, MR; Dallas-Yang, Q; Jiang, G; Langdon, RB; Li, Z; Miller, C; Mu, J; Muise, ES; Parmee, ER; Qureshi, SA; Wu, MS; Xiong, Y; Yang, X; Zhang, BB | 1 |
| Dhanjal, JK; Goyal, S; Grover, A; Grover, S; Sundar, D | 1 |
| Bergman, A; Erion, DM; Kazierad, DJ; Lee, DS; Rolph, T; Somayaji, V; Tan, B | 1 |
| Andrews, SP; Baig, AH; Bortolato, A; Brown, AJ; Cooke, RM; Doré, AS; Errey, JC; Jazayeri, A; Koglin, M; Krishnamurthy, H; Lamb, D; Marshall, FH; Robertson, NJ; Southall, SM; Teobald, I; Weir, M | 1 |
1 trial(s) available for glucagon and beta-alanine
| Article | Year |
|---|---|
Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Alanine Transaminase; Amino Acids; Aspartate Aminotransferases; beta-Alanine; Blood Glucose; C-Peptide; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Pyrazoles; Receptors, Glucagon; Sulfonylurea Compounds | 2016 |
6 other study(ies) available for glucagon and beta-alanine
| Article | Year |
|---|---|
Characterization of L-glutamine transport by pulmonary artery endothelial cells.
Topics: Amino Acids; Animals; beta-Alanine; Biological Transport; Cells, Cultured; Dexamethasone; Endothelium, Vascular; Glucagon; Glutamine; Hydrogen-Ion Concentration; Insulin; Kinetics; Pulmonary Artery; Sodium; Swine | 1991 |
No evidence for a tumor necrosis factor alpha stimulated 2-methylaminoisobutyric acid uptake in hepatocyte monolayer.
Topics: Animals; beta-Alanine; Biological Transport; Cells, Cultured; Glucagon; In Vitro Techniques; Interferon-gamma; Liver; Male; Rats; Rats, Sprague-Dawley; Serum Albumin; Tumor Necrosis Factor-alpha | 1995 |
Discovery of a novel glucagon receptor antagonist N-[(4-{(1S)-1-[3-(3, 5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the treatment of type II diabetes.
Topics: Animals; Area Under Curve; beta-Alanine; Blood Glucose; CHO Cells; Cricetinae; Cricetulus; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Dogs; Glucagon; Glucagon-Like Peptide-1 Receptor; Humans; Inhibitory Concentration 50; Macaca mulatta; Mice; Mice, Obese; Microsomes, Liver; Pyrazoles; Rats; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I; Receptors, Vasoactive Intestinal Peptide, Type II; Receptors, Vasoactive Intestinal Polypeptide, Type I | 2012 |
Anti-diabetic efficacy and impact on amino acid metabolism of GRA1, a novel small-molecule glucagon receptor antagonist.
Topics: Administration, Oral; Animals; beta-Alanine; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Expression Regulation; Glucagon; Glycogen; Glycogenolysis; Hepatocytes; Hormones; Humans; Hypoglycemic Agents; Iodine Radioisotopes; Liver; Macaca mulatta; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Chemical; Pyrazoles; Receptors, Glucagon | 2012 |
Computational identification of novel natural inhibitors of glucagon receptor for checking type II diabetes mellitus.
Topics: beta-Alanine; Blood Glucose; Computational Biology; Diabetes Mellitus, Type 2; Glucagon; High-Throughput Screening Assays; Humans; Liver; Molecular Dynamics Simulation; Peptide Library; Pharmaceutical Preparations; Protein Binding; Protein Conformation; Pyrazoles; Receptors, Glucagon | 2014 |
Extra-helical binding site of a glucagon receptor antagonist.
Topics: Allosteric Site; beta-Alanine; Crystallography, X-Ray; Glucagon; Humans; Ligands; Lipid Bilayers; Models, Molecular; Protein Conformation; Pyrazoles; Receptors, Corticotropin-Releasing Hormone; Receptors, Glucagon | 2016 |